Crip3-flox Mouse

Crip3, a member of the cysteine-rich intestinal protein (CRIP) family, belongs to the Lin-1, Isl1, Mec3/double zinc finger protein family. The CRIP family plays important roles in cellular epithelial-mesenchymal transition, cell death, and tumor progression, and participates in multiple signaling pathways [1].

In terms of disease-related findings, a rare-variant association analysis revealed an association between Crip3 and age-related hearing loss, suggesting that rare-variants in Crip3 may play a role in the etiology of this condition [2]. Meta-analysis of RNA-seq data under oxidative stress conditions showed that Crip3 was downregulated, indicating a possible relationship between oxidative stress and zinc homeostasis [3]. In Xenopus laevis embryogenesis, Crip3 was expressed in the cranial ganglions and the heart, suggesting its potential role in embryonic development [4]. In prostate cancer, a methylation panel including Crip3 was significantly associated with biochemical recurrence and could prognosticate the initiation of salvage radiotherapy and/or hormone therapy after radical prostatectomy [5]. In heart failure, Crip3 was identified as a novel contributor to the pathogenesis [6]. An 8-gene HPV-related prognostic model for squamous cell carcinoma of the head and neck included Crip3 [7]. In a study on blood pressure, a genetic association was detected between pulse pressure and a locus near Crip3 [8]. For prostate cancer patients on active surveillance, a 3-marker panel consisting of miR-24, miR-30c and Crip3 methylation was significant for predicting patient reclassification [9]. In lung squamous cell carcinoma, Crip3 was among the markers specifically hypermethylated in the high-methylation subgroup, which was related to prognosis [10].

In conclusion, Crip3 is involved in various biological processes such as embryonic development, and is associated with multiple diseases including age-related hearing loss, prostate cancer, heart failure, squamous cell carcinoma of the head and neck, and lung squamous cell carcinoma. The study of Crip3 in these contexts helps to understand the molecular mechanisms underlying these diseases and may provide potential targets for diagnosis and treatment.